NSTM 株価推移チャート
NSTM 財務
Novelstem International Corp
$0
0%
$0
終値： Jun 23, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Jun 23, 20:00:00 GMT-4
戻る
Novelstem International Corp (NSTM) 財務
収入
貸借対照表
現金の流れ
年次
四半期
NSTM 収入
金額は百万米ドル単位。会計年度は2月から1月まで。
Follow-Up Questions
Novelstem International Corpの主要な財務諸表は何ですか？
NSTMの主要な財務比率は何ですか？
Novelstem International Corpの収益はセグメントまたは地域別にどのように分けられていますか？
Novelstem International Corpは収益を上げていますか？
Novelstem International Corpに負債はありますか？
Novelstem International Corpの発行済株式数は何株ですか？
主要データ
前終値
$0.01
始値
--
当日レンジ
-
52週レンジ
-
取引高
--
平均取引高
--
配当利回り
--
1株当たり利益(TTM)
--
時価総額
--
NSTMとは何ですか？
NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company is headquartered in Boca Raton, Florida. The firm's primary assets are NewStem Ltd (NewStem) and NetCo Partners (NetCo). NewStem focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. NewStem is principally focused on utilizing proprietary human Pluripotent Stem Cells (hPSCs) and Haploid human Pluripotent Stem Cells (HhPSCs) in the development of diagnostic and therapeutic products in oncology. Its NewStem Software Diagnostic Device (NSDD) is a bioinformatics-based software medical device platform that provides oncologists with information regarding the presence of mutations in tumors, which may confer patient resistance to certain anti-cancer drugs. NetCo is a media business interest which owns Net Force, a book publishing franchise.
